Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Insulin glargine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Insulin glargine 100units/ml inj 3ml pf dispos dev
0601012V0AAADAD
|
Insulin glargine | Insulin glargine | Endocrine System | 10,209 |
|
Insulin glargine 100units/ml inj 3ml cartridges
0601012V0AAAAAA
|
Insulin glargine | Insulin glargine | Endocrine System | 3,478 |
|
Insulin glargine 300units/ml inj 1.5ml pf dispos dev
0601012V0AAAEAE
|
Insulin glargine | Insulin glargine | Endocrine System | 913 |
|
Insulin glargine 100units/ml inj 10ml vials
0601012V0AAABAB
|
Insulin glargine | Insulin glargine | Endocrine System | 329 |
|
Insulin glargine 300units/ml inj 3ml pf disposable devices
0601012V0AAAFAF
|
Insulin glargine | Insulin glargine | Endocrine System | 220 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.